• Department of Ophthalmology, Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine 200011, China;
Ji Jing, Email: flowerrainday@sina.com
Export PDF Favorites Scan Get Citation

Retinal degeneration mainly include age-related macular degeneration, retinitispigmentosa and Stargardt’s disease. Although its expression is slightly different, its pathogenesis is photoreceptor cells and/or retinal pigment epithelial (RPE) cel1 damage or degeneration. Because of the 1ack of self-repairing and renewal of retinal photoreceptor cells and RPE cells, cell replacement therapy is one of the most effective methods for treating such diseases.The stem cells currently used for the treatment of retinal degeneration include embryonicstem cells (ESC) and various adult stem cells, such as retinal stem cells (RSC), induced pluripotent stem cells (iPSC). and mesenchyma1 stem cells (MSC). Understanding the currentbasic and clinical application progress of ESC, iPSC, RSC, MSC can provide a new idea for the treatment of retinal degeneration.

Citation: Sun Na, Gu Ping, Ji Jing. Advances of stem cell transplantation in the treatment of retinal degeneration. Chinese Journal of Ocular Fundus Diseases, 2018, 34(6): 613-617. doi: 10.3760/cma.j.issn.1005-1015.2018.06.021 Copy

  • Previous Article

    Advances in the genetics of familial exudative vitreoretinopathy